FY24 saw an 11.2% sales decline and a $48.3m statutory loss, driven by lower consumer demand and a $40.3m Oboz goodwill impairment. Gross margin held steady, cost controls improved, and the group remains focused on margin and profitability recovery in FY25.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.